Romania · Delayed Price · Currency is RON Biofarm Statistics
Total Valuation
Biofarm has a market cap or net worth of RON 1.42 billion. The enterprise value is 1.19 billion.
| Market Cap | 1.42B |
| Enterprise Value | 1.19B |
Important Dates
The last earnings date was Tuesday, May 5, 2026.
| Earnings Date | May 5, 2026 |
| Ex-Dividend Date | Jun 29, 2026 |
Share Statistics
Biofarm has 985.37 million shares outstanding. The number of shares has increased by 0.75% in one year.
| Current Share Class | 985.37M |
| Shares Outstanding | 985.37M |
| Shares Change (YoY) | +0.75% |
| Shares Change (QoQ) | -30.31% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | 88.43% |
| Float | 476.14M |
Valuation Ratios
The trailing PE ratio is 15.60.
| PE Ratio | 15.60 |
| Forward PE | n/a |
| PS Ratio | 4.46 |
| PB Ratio | 2.44 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | 18.85 |
| P/OCF Ratio | 15.33 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 10.17, with an EV/FCF ratio of 15.79.
| EV / Earnings | 11.79 |
| EV / Sales | 3.74 |
| EV / EBITDA | 10.17 |
| EV / EBIT | 12.24 |
| EV / FCF | 15.79 |
Financial Position
The company has a current ratio of 4.93, with a Debt / Equity ratio of 0.00.
| Current Ratio | 4.93 |
| Quick Ratio | 4.26 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | 0.01 |
| Debt / FCF | 0.02 |
| Interest Coverage | 55.83 |
Financial Efficiency
Return on equity (ROE) is 18.48% and return on invested capital (ROIC) is 23.23%.
| Return on Equity (ROE) | 18.48% |
| Return on Assets (ROA) | 9.58% |
| Return on Invested Capital (ROIC) | 23.23% |
| Return on Capital Employed (ROCE) | 16.66% |
| Weighted Average Cost of Capital (WACC) | 6.78% |
| Revenue Per Employee | 862,025 |
| Profits Per Employee | 273,278 |
| Employee Count | 369 |
| Asset Turnover | 0.50 |
| Inventory Turnover | 0.87 |
Taxes
In the past 12 months, Biofarm has paid 14.67 million in taxes.
| Income Tax | 14.67M |
| Effective Tax Rate | 12.70% |
Stock Price Statistics
The stock price has increased by +111.77% in the last 52 weeks. The beta is 0.44, so Biofarm's price volatility has been lower than the market average.
| Beta (5Y) | 0.44 |
| 52-Week Price Change | +111.77% |
| 50-Day Moving Average | 1.30 |
| 200-Day Moving Average | 1.00 |
| Relative Strength Index (RSI) | 67.60 |
| Average Volume (20 Days) | 181,426 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Biofarm had revenue of RON 318.09 million and earned 100.84 million in profits. Earnings per share was 0.09.
| Revenue | 318.09M |
| Gross Profit | 272.29M |
| Operating Income | 97.07M |
| Pretax Income | 115.51M |
| Net Income | 100.84M |
| EBITDA | 116.90M |
| EBIT | 97.07M |
| Earnings Per Share (EPS) | 0.09 |
Balance Sheet
The company has 231.51 million in cash and 1.13 million in debt, with a net cash position of 230.37 million or 0.23 per share.
| Cash & Cash Equivalents | 231.51M |
| Total Debt | 1.13M |
| Net Cash | 230.37M |
| Net Cash Per Share | 0.23 |
| Equity (Book Value) | 580.88M |
| Book Value Per Share | 0.59 |
| Working Capital | 369.95M |
Cash Flow
In the last 12 months, operating cash flow was 92.53 million and capital expenditures -17.27 million, giving a free cash flow of 75.26 million.
| Operating Cash Flow | 92.53M |
| Capital Expenditures | -17.27M |
| Depreciation & Amortization | 19.83M |
| Net Borrowing | n/a |
| Free Cash Flow | 75.26M |
| FCF Per Share | 0.08 |
Margins
Gross margin is 85.60%, with operating and profit margins of 30.52% and 31.70%.
| Gross Margin | 85.60% |
| Operating Margin | 30.52% |
| Pretax Margin | 36.31% |
| Profit Margin | 31.70% |
| EBITDA Margin | 36.75% |
| EBIT Margin | 30.52% |
| FCF Margin | 23.66% |
Dividends & Yields
This stock pays an annual dividend of 0.04, which amounts to a dividend yield of 2.92%.
| Dividend Per Share | 0.04 |
| Dividend Yield | 2.92% |
| Dividend Growth (YoY) | 487.94% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 29.00% |
| Buyback Yield | -0.75% |
| Shareholder Yield | 2.16% |
| Earnings Yield | 7.11% |
| FCF Yield | 5.30% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on April 30, 2008. It was a forward split with a ratio of 1.12001.
| Last Split Date | Apr 30, 2008 |
| Split Type | Forward |
| Split Ratio | 1.12001 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 5 |